NIH VideoCast - New Approaches to Detect, Study and Treat SARS-CoV-2 Infection

Skip Navigation

New Approaches to Detect, Study and Treat SARS-CoV-2 Infection

Loading... Loading video...

921 Views

Air date:	Thursday, January 6, 2022, 12:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 921 (661 Live, 260 On-demand)
Category:	COVID-19
Runtime:	01:03:50
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	COVID-19 Scientific Interest Group lecture series Dr. Ott leads the Gladstone Institute of Virology and is a professor of medicine at the University of California, San Francisco. She has made seminal contributions to our understanding of how viruses such as HIV, hepatitis C, Zika, and now SARS-CoV-2 hijack and interface with host cells to replicate and propagate themselves. She has been at the forefront of pan-viral drug discovery efforts, identifying drugs that target multiple different viruses, including HIV and SARS-CoV-2. Omicron is a reminder that the current pandemic requires continuous focus on innovative new tools, therapies and testing. We will discuss advances in CRISPR testing, host directed therapies and recombinant viruses to get ahead of new variants. Objectives: introduce new CRISPR direct detection methods for SARS-CoV-2; discuss host directed therapies against SARS-CoV-2; describe new virus-like particle and recombinant virus generation for SARS-CoV-2. For more information go to https://www.niaid.nih.gov/research/covid-19-sig

NLM Title:	New approaches to detect, study and treat SARS-CoV-2 infection / Melanie Ott.
Author:	Ott, Melanie. National Institutes of Health (U.S.). COVID-19 Scientific Interest Group,
Publisher:
Abstract:	(CIT): Dr. Ott leads the Gladstone Institute of Virology and is a professor of medicine at the University of California, San Francisco. She has made seminal contributions to our understanding of how viruses such as HIV, hepatitis C, Zika, and now SARS-CoV-2 hijack and interface with host cells to replicate and propagate themselves. She has been at the forefront of pan-viral drug discovery efforts, identifying drugs that target multiple different viruses, including HIV and SARS-CoV-2. Omicron is a reminder that the current pandemic requires continuous focus on innovative new tools, therapies and testing. We will discuss advances in CRISPR testing, host directed therapies and recombinant viruses to get ahead of new variants. Objectives: introduce new CRISPR direct detection methods for SARS-CoV-2; discuss host directed therapies against SARS-CoV-2; describe new virus-like particle and recombinant virus generation for SARS-CoV-2.
Subjects:	COVID-19--diagnosis COVID-19--therapy Clustered Regularly Interspaced Short Palindromic Repeats SARS-CoV-2--isolation & purification Therapies, Investigational
Publication Types:	Lecture Webcast

NLM Classification:	WC 506.2
NLM ID:	9918351573406676
CIT Live ID:	44471
Permanent link:	https://videocast.nih.gov/watch=44471

Related Videos...